Related Experiment Video
Updated: Jul 16, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins
K R Ostler1, E M Davis, S L Payne
1Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.
Abstract:
Cancer cells display an altered distribution of DNA methylation relative to normal cells. Certain tumor suppressor gene promoters are hypermethylated and transcriptionally inactivated, whereas repetitive DNA is hypomethylated and transcriptionally active. Little is understood about how the abnormal DNA methylation patterns of cancer cells are established and maintained. Here, we identify over 20 DNMT3B transcripts from many cancer cell lines and primary acute leukemia cells that contain aberrant splicing at the 5' end of the gene, encoding truncated proteins lacking the C-terminal catalytic domain. Many of these aberrant transcripts retain intron sequences. Although the aberrant transcripts represent a minority of the DNMT3B transcripts present, Western blot analysis demonstrates truncated DNMT3B isoforms in the nuclear protein extracts of cancer cells. To test if expression of a truncated DNMT3B protein could alter the DNA methylation patterns within cells, we expressed DNMT3B7, the most frequently expressed aberrant transcript, in 293 cells. DNMT3B7-expressing 293 cells have altered gene expression as identified by microarray analysis. Some of these changes in gene expression correlate with altered DNA methylation of corresponding CpG islands. These results suggest that truncated DNMT3B proteins could play a role in the abnormal distribution of DNA methylation found in cancer cells.
Insights
Aberrant splicing of DNA methyltransferase 3B (DNMT3B) in cancer cells produces truncated proteins. These truncated DNMT3B variants may contribute to abnormal DNA methylation patterns observed in tumors.
Area of Science:
- Cancer Biology
- Epigenetics
- Molecular Oncology
Background:
- Cancer cells exhibit distinct DNA methylation patterns compared to normal cells.
- Hypermethylation of tumor suppressor genes and hypomethylation of repetitive DNA are characteristic of cancer.
- Mechanisms underlying aberrant DNA methylation in cancer remain largely unknown.
Purpose of the Study:
- To investigate the role of aberrant DNA methyltransferase 3B (DNMT3B) transcripts in cancer.
- To determine if truncated DNMT3B proteins can alter DNA methylation and gene expression.
Main Methods:
- Identification and characterization of DNMT3B transcripts in cancer cell lines and primary leukemia cells.
- Western blot analysis to detect truncated DNMT3B isoforms.
- Expression of DNMT3B7 in 293 cells followed by microarray analysis and CpG island methylation analysis.
Main Results:
- Over 20 aberrant DNMT3B transcripts, many retaining introns and encoding truncated proteins, were identified in cancer cells.
- Truncated DNMT3B isoforms were detected in nuclear extracts of cancer cells.
- Expression of DNMT3B7 led to altered gene expression and DNA methylation of CpG islands in 293 cells.
Conclusions:
- Aberrantly spliced DNMT3B transcripts producing truncated proteins are present in cancer cells.
- Truncated DNMT3B proteins have the potential to influence DNA methylation patterns and gene expression.
- These findings suggest a novel mechanism by which cancer cells establish abnormal DNA methylation profiles.
Related Concept Videos
Abnormal Proliferation
RNA Splicing
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...